Pablo Demelo‐Rodríguez

Dr. Pablo Demelo‐Rodríguez

Hospital General Universitario Gregorio Marañón, Madrid, Spain
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
PDPaola Ditano-Vázquez
Paola Ditano-Vázquez
JTJose David Torres-Peña
Jose David Torres-Peña
FGFrancisco Galeano-Valle
Francisco Galeano-Valle
JDJavier Delgado-Lista
Javier Delgado-Lista
Pablo Demelo‐RodríguezPablo Demelo‐Rodríguez
Pablo Demelo‐Rodríguez
LALuis Antonio Alvarez-Sala-Walther
Luis Antonio Alvarez-Sala-Walther
A growing interest has emerged in the beneficial effects of plant-based diets for the prevention of cardiovascular disease, diabetes and obesity. The Mediterranean diet, one of the most widely evaluated dietary patterns in scientific literature, includes in its nutrients two fluid foods: olive oil, as the main source of fats, and a low-to-moderate consumption of wine, mainly red, particularly during meals. Current mechanisms underlying the beneficial effects of the Mediterranean diet include a reduction in inflammatory and oxidative stress markers, improvement in lipid profile, insulin sensitivity and endothelial function, as well as antithrombotic properties. Most of these effects are attributable to bioactive ingredients including polyphenols, mono- and poly-unsaturated fatty acids. Polyphenols are a heterogeneous group of phytochemicals containing phenol rings. The principal classes of red wine polyphenols include flavonols (quercetin and myricetin), flavanols (catechin and epicatechin), anthocyanin and stilbenes (resveratrol). Olive oil has at least 30 phenolic compounds. Among them, the main are simple phenols (tyrosol and hydroxytyrosol), secoroids and lignans. The present narrative review focuses on phenols, part of red wine and virgin olive oil, discussing the evidence of their effects on lipids, blood pressure, atheromatous plaque and glucose metabolism.

4 August 2020 in European Journal of Haematology
Verified
Journal Article
Closed access
PDF file
RMReyes Maria Martin-Rojas
Reyes Maria Martin-Rojas
GPGloria Pérez‐Rus
Gloria Pérez‐Rus
VDValeria Estefania Delgado‐Pinos
Valeria Estefania Delgado‐Pinos
ADAmalia Domingo‐González
Amalia Domingo‐González
IRIsabel Regalado‐Artamendi
Isabel Regalado‐Artamendi
CPCristina Pascual-Izquierdo
Cristina Pascual-Izquierdo

1 August 2020 in Thrombosis Research
Verified
Journal Article
Closed access
FGFrancisco Galeano-Valle
Francisco Galeano-Valle
COC.M. Oblitas
C.M. Oblitas
MFM.M. Ferreiro-Mazón
M.M. Ferreiro-Mazón
JAJ. Alonso-Muñoz
J. Alonso-Muñoz
JTJ. del Toro-Cervera
J. del Toro-Cervera
Pablo Demelo‐RodríguezPablo Demelo‐Rodríguez
Pablo Demelo‐Rodríguez

Verified
Journal Article
Open access
PDF file
FGFrancisco Galeano-Valle
Francisco Galeano-Valle
LOLucia Ordieres Ortega
Lucia Ordieres Ortega
COCrhistian-Mario Oblitas
Crhistian-Mario Oblitas
JDJorge del-Toro-Cervera
Jorge del-Toro-Cervera
LALuis Antonio Alvarez-Sala-Walther
Luis Antonio Alvarez-Sala-Walther
Pablo Demelo‐RodríguezPablo Demelo‐Rodríguez
Pablo Demelo‐Rodríguez
The relationship between inflammation and venous thrombosis is not well understood. An inflammatory response may be both the cause and consequence of venous thromboembolism (VTE). In fact, several risk factors of VTE modulate thrombosis through inflammatory markers. Acute pulmonary embolism (PE) is burdened by a remarkable mortality rate, up to 34% in severely ill patients presenting with hemodynamic instability. Initial mortality risk stratification is based on hemodynamic instability. Patients with a situation of hemodynamic stability require immediate further risk assessment based on clinical, imaging, and circulating biomarkers, as well as the presence of comorbidities. Some inflammatory biomarkers have shown potential usefulness in the risk stratification of patients with VTE, especially acute PE. C-reactive protein on admission is associated with 30-day mortality and bleeding in VTE patients. P-selectin is associated with right ventricle dysfunction in PE patients and might be associated with VTE recurrences and the extension of thrombosis. Tissue factor microparticles are associated with VTE recurrence in cancer-associated thrombosis. Other inflammatory biomarkers present scarce evidence (inflammatory cytokines, erythrocyte sedimentation rate, fibrinogen, leukocyte count). In this manuscript, we will review the prognostic role of different inflammatory biomarkers available both for clinical practice and research in VTE patients.

21 May 2021 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
Pablo Demelo‐RodríguezPablo Demelo‐Rodríguez
Pablo Demelo‐Rodríguez
AFAna Isabel Farfán-Sedano
Ana Isabel Farfán-Sedano
JPJosé María Pedrajas
José María Pedrajas
PLPilar Llamas
Pilar Llamas
PSPatricia Sigüenza
Patricia Sigüenza
TIThe RIETE-BLEEDING Investigators
The RIETE-BLEEDING Investigators

1 May 2020 in Thrombosis Research
Verified
Journal Article
Closed access
LOL. Ordieres-Ortega
L. Ordieres-Ortega
Pablo Demelo‐RodríguezPablo Demelo‐Rodríguez
Pablo Demelo‐Rodríguez
FGFrancisco Galeano-Valle
Francisco Galeano-Valle
BKB.M.M. Kremers
B.M.M. Kremers
ACA.J. Ten Cate-Hoek
A.J. Ten Cate-Hoek
HCH. Ten Cate
H. Ten Cate